Skip to content
Men Under Microscope – Lifestyle
Home
Sample Page
Author:
BioStem Technologies, Inc.
BioStem Technologies Announces Nasdaq Uplisting
August 6, 2026
BioStem Technologies to Host Second Quarter 2026 Financial Results Conference Call on August 12, 2026
July 29, 2026
BioStem Technologies Publicly Files Form 10 Registration Statement with the Securities and Exchange Commission
July 10, 2026
BioStem Technologies Announces Issuance of Four U.S. Design Patents Covering Fenestrated Human Placental Allograft Technologies
July 8, 2026
BioStem Technologies to Present at the Planet MicroCap Las Vegas 2026 Conference
June 10, 2026
BioStem Technologies Announces Appointment of Three New Members to its Board of Directors
June 9, 2026
BioStem Technologies Announces $2.5 Million Private Placement Financing with its First Institutional Investor
May 22, 2026
BioStem Technologies Announces Notice of Allowance for Four U.S. Design Patent Applications Covering Fenestrated Human Placental Allografts and One European Patent
May 20, 2026
BioStem Technologies Reports First Quarter 2026 Financial Results
May 15, 2026
BioStem Technologies to Present at the 16th Annual LD Micro Invitational
May 12, 2026
1
2
Next Page
→